// App-Quantinova.ai

TCT-11 : Everolimus-Eluting Bioresorbable Scaffolds Versus Drug-Eluting Stents in Patients With Acute Myocardial Infarction: 2-Year Results of the Randomized ISAR-Absorb MI Trial

Researchers

Presenter

  • Jens Wiebe

Principal Investigators

  • Simon Schneider

  • Salvatore Cassese

  • Himanshu Rai

  • Petra Hoppmann

  • Roisin Colleran

  • Fernando Alfonso

  • Michael Maeng

  • Evgeny Kretov

  • Michael Joner

  • Karl-Ludwig Laugwitz

  • Adnan Kastrati

  • Robert Byrne

Medical Centers

  • Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

  • Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Munich, Germany

  • National Medical Research Center named after E.N. Meshalkin, Novosibirsk, Russian Federation

  • German Heart Center Munich, Munich, Germany

  • Deutsches Herzzentrum Munchen, Munich, Germany

  • Hospital Universitario de la Princesa, Madrid, Spain

  • Aarhus University Hospital, Aarhus, Denmark

  • ISAResearch Centre, Deutsches Herzzentrum München (German Heart Centre Munich), Munich, Germany

Locations

  • Germany

  • Russia

  • Spain

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Myocardial infarction

  • Complex calcified coronary artery lesions

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

  • Non Inferiority

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved